Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Insilico Biotechnology
Insilico Biotechnology
Activities:
Ingredients
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Yokogawa acquires bioprocessing digital twin expert
The company has acquired Insilico Biotechnology to build its biopharma offering
Finance
Insilico and 2-control work towards the smart biofactory
The agreement follows Insilico's previous collaboration with Meyer Chroma Technology
Manufacturing
Insilico Biotechnology moves into the US predictive twin market
Insilico Biotechnology has announced the opening of its first subsidiary in the US, located in Boston, Massachusetts
Manufacturing
Insilico and Janssen take another step towards predictive biomanufacturing
The digital twins collaboration will run for three years and will be based at Insilico's site in Stuttgart, Germany and at Janssen's Spring House location in the US
Manufacturing
Insilico works with university on digital twins for antibody production
The German collaboration aims to enable true online-control of critical quality attributes such as the glycosylation profile
Subscribe now